Industry Experts

Jon Levenson is the Chief Scientific Officer at FireCyte Therapeutics and has over 18 years of experience as a neuroscientist in neuropsychiatry, neurodegeneration, and neuroinflammation. He has a PhD in Biology from the University of Houston and did his postdoctoral training at Baylor College of Medicine in the Department of Neuroscience. Prior to FireCyte, Jon was Vice President of Translational Medicine at Tiaki Therapeutics, where he helped develop an integrated neuroinflammatory translational platform that recapitulated disease processes occurring in patients. He was the head of preclinical and nonclinical research and development at Proclara Biosciences, where he was key in moving two assets that targeted amyloid aggregates into the clinic. He has held academic appointments at the University of Wisconsin-Madison and Baylor College of Medicine.